Advertisement
Advertisement

NAGE

NAGE logo

Niagen Bioscience, Inc. Common Stock

3.12
USD
Sponsored
+0.08
+2.63%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

3.08

-0.04
-1.28%

Niagen Bioscience, Inc. Common Stock Profile

About

Niagen Bioscience Inc. is a nicotinamide adenine dinucleotide science and healthy-aging research company. Niagen Bioscience Inc., formerly known as ChromaDex Corp., is based in LOS ANGELES.

Info & Links

CEO

Robert Fried

Headquarters

10900 Wilshire Blvd. Suite 600
Los Angeles, CA 90024, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.niagenbioscience.com

Auditor

Crowe LLP

Share holders

30

Employees

117

Niagen Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

243.71M

Enterprise Value

176.97M

Enterprise Value/EBITDA(ttm)

15.29

Price to Earnings Ratio(ttm)

19.50

Price to Sales(ttm)

1.93

Price to Book(mrq)

3.01

Price to Cash(ytd)

15.39

Profitability

Gross Margin(ttm)

64.24%

Operating Margin(ttm)

10.85%

Profit Margin(ttm)

12.25%

Return on Equity(ttm)

17.95%

Return on Invested Capital(ttm)

20.72%

Return on Assets(ttm)

13.17%

Income Statement

Revenue(ttm)

129.08M

Revenue Per Share(ttm)

1.63

Gross Profit(ttm)

82.92M

EBITDA(ttm)3

11.57M

Net Income Available to Common(ttm)

15.99M

Diluted EPS(ttm)

0.18

Share Statistics

Beta (5Y Monthly)

2.09

52-Week Change

-67.93%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

79.13M

Dividend Yield

0.00%

Float4

71.68M

% Held by Insiders

10.00%

% Held by Institutions

15.41%

Balance Sheet

Total Cash(mrq)

66.74M

Total Cash Per Share(mrq)

0.84

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.50%

Quick Ratio(mrq)

3.55%

Book Value Per Share(mrq)

1.05

Cash Flow

Operating Cash Flow Per Share(ytd)

0.02

Free Cash Flow(ytd)

7.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement